Neoadjuvant Therapy for Rectal Cancer: Improved Tumor Response, Local Recurrence, and Overall Survival in Nonanemic Patients

医学 放化疗 贫血 结直肠癌 内科学 全直肠系膜切除术 外科 胃肠病学 癌症
作者
Ben Box,Ian Lindsey,James Wheeler,Bryan F. Warren,Chris Cunningham,Bruce George,N J McC Mortensen,A Jones
出处
期刊:Diseases of The Colon & Rectum [Lippincott Williams & Wilkins]
卷期号:48 (6): 1153-1160 被引量:25
标识
DOI:10.1007/s10350-004-0939-7
摘要

Preoperative, long-course chemoradiotherapy is recommended for rectal cancers involving or threatening the mesorectal resection margin, but tumor response is variable. Some highly radiosensitive cancers completely regress, leading to reduced local recurrence and improved survival. This study was designed to evaluate the influence of anemia during chemoradiotherapy on tumor response, local and distant recurrence, and overall survival.Mean hemoglobins during chemoradiotherapy of consecutive patients with rectal cancer undergoing chemoradiotherapy and surgery were calculated and ranked. Anemia was defined as lowest quartile for males and females. Tumor response was histologically quantified using rectal cancer regression grade.Of 100 patients, 5 females and 20 males were anemic. Nonanemic patients achieved better tumor response (54 percent regression Grade 1) than anemic patients (28 percent, P = 0.028). There were more locally advanced cancers in anemic (48 percent T4) compared with nonanemic patients (21 percent T4), but radiologic T stage did not influence tumor response (50 percent T3 vs. 43 percent T4 regression Grade 1, P = 0.53) or overall survival. Mesorectal margin positivity was less in nonanemic (15 percent) compared with anemic patients (36 percent, P = 0.021). At median follow-up of 39 months, nonanemic patients (7 percent) suffered less local recurrence than anemic patients did (38 percent, P = 0.003). Overall survival at two years was improved in nonanemic (91 percent) compared with anemic patients (64 percent, P = 0.021), but was similar for T3 and T4 patients.Patients with normal hemoglobin during chemoradiotherapy achieved better tumor response, less local recurrence, and improved overall survival compared with anemic patients, independent of radiologic T stage. Correcting anemia before chemoradiotherapy might improve tumor response and oncologic outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
冷静如松完成签到 ,获得积分10
5秒前
7秒前
浮云完成签到 ,获得积分10
8秒前
屈岂愈完成签到,获得积分10
9秒前
23秒前
Pupil完成签到,获得积分10
23秒前
偏偏意气用事完成签到,获得积分10
24秒前
安安完成签到,获得积分10
28秒前
cttc完成签到,获得积分10
29秒前
Chnimike完成签到 ,获得积分10
29秒前
33秒前
红茸茸羊完成签到 ,获得积分10
33秒前
年轻千愁完成签到 ,获得积分10
35秒前
liu完成签到,获得积分10
36秒前
量子星尘发布了新的文献求助10
36秒前
Wanyeweiyu完成签到,获得积分10
38秒前
Fury完成签到 ,获得积分10
43秒前
风中幻梦完成签到,获得积分10
45秒前
bigpluto完成签到,获得积分10
46秒前
48秒前
是谁还没睡完成签到 ,获得积分10
49秒前
盘尼西林发布了新的文献求助10
53秒前
zzz完成签到 ,获得积分10
55秒前
dktrrrr完成签到,获得积分10
57秒前
科研通AI2S应助科研通管家采纳,获得10
57秒前
丘比特应助科研通管家采纳,获得20
57秒前
57秒前
ccc完成签到,获得积分10
1分钟前
萧秋灵完成签到,获得积分10
1分钟前
缓慢冥幽完成签到,获得积分10
1分钟前
旺仔同学完成签到,获得积分10
1分钟前
吉以寒完成签到,获得积分10
1分钟前
科研老兵完成签到,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
fys131415完成签到 ,获得积分10
1分钟前
执着的忆雪完成签到 ,获得积分10
1分钟前
1分钟前
闵不悔完成签到,获得积分10
1分钟前
阳光火车完成签到 ,获得积分10
1分钟前
cc完成签到,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038066
求助须知:如何正确求助?哪些是违规求助? 3575779
关于积分的说明 11373801
捐赠科研通 3305584
什么是DOI,文献DOI怎么找? 1819239
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022